Treatment of prostate cancer is often confusing for patients, but ProstaVysion™ – the first personalized genetic panel for prostate cancer – optimizes that choice by defining the aggressiveness of the cancer. Exclusively from Bostwick Laboratories® and available immediately, ProstaVysionTM examines the genetic status of that patient’s prostate cancer.
